Impaired renal function in type 2 diabetes patients in the absence of increased urine albumin excretion rate

Diabetologia Doswiadczalna i Kliniczna

Volumn 8, Issue 4, 2008, Pages 165-168

  Walczak, Konrad ^a   Sodolska, Małgorzata ^a   Materek, Izabela ^a   Krysicka, Anna ^a   Moczulski, Dariusz ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Klinika Chorób Wewnetrznych i Nefrodiabetologii ^*  (Poland)

Author keywords

Albuminuria; Chronic kidney disease; Glomerular filtration rate

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

EID: 62349084361     PISSN: 16433165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil KJ, Jerums G: Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 2004; 27: 195-200.
2. th Annual Scientific Sessions 2006 (Abstract 24-OR).
3. 1 Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003; 289: 3273-3277.
4. Silveiro SP, Friedman R, de Azevedo MJ, Canani LH, Gross JL. Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabetes Care 1996; 19: 171-174.
5. Murussi M, Gross JL, Silveiro SP. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric type 2 diabetic patients and normal individuals. A 10-year follow-up. J Diab Compl 2006; 20: 210-215.
6. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007; 49 (suppl 2): S21-S139.
7. American Diabetes Association. Executive Summary. Standards of medical care in diabetes 2008. Diabetes Care 2008; 31 (suppl 1): S5-S11.
8. American Diabetes Association. Standards of medical care in diabetes 2006. Diabetes Care 2006; 29 (suppl 1): S4-S42.
9. Spijkerman AM, Dekker JM, Nijpels G. et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn screening study. Diabetes Care 2003; 26: 2604-2608.
10. Nazimek-Siewniak B, Moczulski D, Grzeszczak W. Risk of macrovascular and microvascular complications in type 2 diabetes: results of longitudinal study design. J Diab Compl 2002; 16: 271-276.
11. Mussap M, Dalla Vestra M, Fioretto P. et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002; 61: 1453-1461.
12. Christensson AG, Grubb AO, Nilsson JA et al. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy. J Intern Med 2004; 256: 510-518.
13. Xia LH, Bing XG, An XT. Serum cystatin C assay for the detection of early renal impairment in diabetic patients. J Clin Lab Anal 2004; 18: 31-35.
14. Perkins BA, Nelson RG, Ostrander BE. et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: Results of a 4-year follow-up study. J Am Soc Nephrol 2005; 16: 1404-1412.